CPRIT Awards $15.4 Million to OncoNano For HPV-Caused Cancer Treatment

Southlake’s OncoNano Medicine, Inc. has been awarded $15.4 million to continue to develop one of its cancer treatment candidates. The funding is from the Cancer Prevention and Research Institute of Texas will go toward pre-clinical and clinical development as well as the first phase of a trial for cancer caused by the human papilloma virus. The treatment is called ONM-500, which delivers antigens while engaging the immunity that already exists in the human body, fighting cervical, head, and neck cancers caused by HPV. CPRIT, which has awarded $2.4 billion in grants to Texas research, has funded the product which was first… Full Story

The University of Puerto Rico Added to Caris Life Sciences Alliance

Caris Life Sciences has just announced that the University of Puerto Rico will be inducted into their Precision Oncology Alliance (POA), making UPR the 28th member. Powered by the molecular science company, the POA is a network of cancer centers working to improve standards of care and practices for the application of molecular profiling in cancer treatment. UPR serves 85 percent of Puerto Rico’s cancer patients and participates in medical research, molecular science, and the development of new drugs and treatments. UPR consists of the UPR Hospital at Carolina, Ambulatory Clinic of UPR, Puerto Rico Medical Center in San Juan,… Full Story

Caris Life Sciences Adds Industry Veteran to its Advisory Board

Dr. Steven D. Averbuch will bring more than three decades of oncology drug experience to Caris Life Sciences’ Scientific Advisory Board after retiring as Vice President and Head of Precision Medicine at Bristol-Myers Squibb. The board is a group of cancer researchers, bioinformaticians and clinical oncologists who help guide and accelerate the work Caris does in improving precision cancer care. Averbuch has been a part of several drug and companion diagnostic approvals in major markets, and recently retired from BMS where he led integrated biomarker and pharmacodiagnostic work in research and development. Averbuch also had leadership roles at Merck Research Laboratories,… Full Story

Caris Life Sciences Adds Florida Cancer Center to its Oncology Alliance

Irving-based Caris Life Sciences will be adding a 26th cancer center to its Precision Oncology Alliance when the Sylvester Comprehensive Cancer Center at the Miami Miller School of Medicine joins the group. The alliance is a network of cancer centers that work together to develop standards of care and best practices to improve cancer treatment. Caris Life Sciences is a biotechnology company that addresses cancer and other diseases through several platforms that inform drug development and other treatment. The Precision Oncology Alliance helps lead the development of precision cancer care, and the Miami center will add to the alliance’s collection of… Full Story

Former UTSW Neuroscience Chair Wins Nobel Prize

Dr. Thomas C. Südhof, adjunct professor of neuroscience and former chairman of the department at UT Southwestern Medical Center, was named a 2013 Nobel Prize winner for medicine Monday, for his and others’ research into how cellular transport systems work. Südhof earned the prize alongside James Rothman and Randy Schekman. “I’m absolutely surprised,” said Südhof. “Every scientist dreams of this. I didn’t realize there was chance I would be awarded the prize. I am stunned and really happy to share the prize with James Rothman and Randy Schekman.” Südhof, now at Stanford University’s medical school, was recognized for work performed at UT Southwestern on… Full Story